市場調査レポート

医薬品ブランドの上市:商品化の成功の方法

Launching Pharmaceutical Brands - Formulas for Commercialization Success

発行 Cutting Edge Information 商品コード 239231
出版日 ページ情報 英文 302 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=104.18円で換算しております。
Back to Top
医薬品ブランドの上市:商品化の成功の方法 Launching Pharmaceutical Brands - Formulas for Commercialization Success
出版日: 2012年04月30日 ページ情報: 英文 302 Pages
概要

医薬品市場の競合状況が激しくなる中、ブランドの商品化成功には、どの分野に、何時、どのように投資するかといった意思決定がこれまでになく重要な役割を果たすようになってきております。

当レポートでは、米国、欧州、その他の主要市場における実際の15ブランドについてベンチマークを実施し、各ブランドについてフェーズ3Aから承認まで、承認から発売日まで、発売日から6ヶ月の期間別の投資状況、個々の支出項目についてまとめ、概略下記の構成でお届けいたします。

第1章 エグゼクティブサマリー

  • ブランド商品化の支出
  • 調査方法と定義
  • 医薬品の商品化:成功のための主な提案

第2章 ブランド1

第3章 ブランド2

第4章 ブランド3

第5章 ブランド4

第6章 ブランド5

第7章 ブランド6

第8章 ブランド7

第9章 ブランド8

第10章 ブランド9

第11章 ブランド10

第12章 ブランド11

第13章 ブランド12

第14章 ブランド13

第15章 ブランド14

第16章 ブランド15

図表

目次
Product Code: PH170

In today's competitive, payer-driven landscape, brand commercialization encompasses a dizzying range of undertakings. Making investment decisions in all of these areas, from promotions to market access to medical affairs, is more complex than ever.

No two companies approach this marketing puzzle in the same way. Lacking a crystal ball, brand teams and their allies invest millions of dollars to create an effective mix and position their drugs for rapid uptake. Their decisions play a critical role in determining whether a product exceeds sales expectations - or falls short of its goals.

This report showcases in-depth investment benchmarks for the launches of 15 real brands in the US, EU and other key markets. These easy-to-navigate brand launch profiles - which address a wide range of competitive pressures, therapeutic areas, resource support scenarios, clinical proficiencies and commercial prospects - serve as models for teams moving toward market:

Win critical resources for commercialization and launch

Explore brand spending benchmarks across five large categories and 15 detailed subcategories. Use this data to avoid underspending in critical areas and overspending in others - and align resources with key strengths and weaknesses.

Focus resources at different points in the launch window

While no two brand launches are identical, companies follow similar patterns in allocating marketing resources - amping up investments as the product moves through development. Follow these patterns as you explore resource data for each brand from Phase 3 through post-launch.

Diversify investments and avoid mistakes

See how other companies handle launch allocations, and learn from their mistakes. Unpack each brand's story to understand why certain decisions were made regarding different marketing tactics and resource allocations.

Benefits:

  • Plan budgets and win necessary resources for commercialization and launch.
  • Pinpoint spending for critical time periods throughout the launch window.
  • Know when and how much to invest in specific areas of advertising and promotion, market access, decision support and medical affairs.
  • Avoid underfunding in critical areas - and overinvesting in others.
  • Use benchmarking data to identify investment levels and patterns among comparable brands.

Table of Contents

Executive Summary

  • Brand Commercialization Spending
  • Methodology and Definitions
  • Pharmaceutical Product Commercialization: Key Recommendations for Suc cess

Brand 1

  • Phase 3a to Market Approval Resources
  • Market Approval to Launch Date Resources
  • Launch Date to 6 Months Post-Launch Resources
  • Individual Spending Categories by Time Frame

Brand 2

  • Phase 3a to Market Approval Resources
  • Market Approval to Launch Date Resources
  • Launch Date to 6 Months Post-Launch Resources

Brand 3

  • Phase 3a to Market Approval Resources
  • Market Approval to Launch Date Resources
  • Launch Date to 6 Months Post-Launch Resources

Brand 4

  • Phase 3a to Market Approval Resources
  • Market Approval to Launch Date Resources
  • Launch Date to 6 Months Post-Launch Resources

Brand 5

  • Phase 3a to Market Approval Resources

Brand 6

  • Phase 3a to Market Approval Resources

Brand 7

  • Phase 3a to Market Approval Resources
  • Market Approval to Launch Date Resources
  • Launch Date to 6 Months Post-Launch Resources

Brand 8

  • Market Approval to Launch Date Resources
  • Launch Date to 6 Months Post-Launch Resources

Brand 9

  • Market Approval to Launch Date Resources
  • Launch Date to 6 Months Post-Launch Resources

Brand 10

  • Phase 3a to Market Approval Resources
  • Market Approval to Launch Date Resources
  • Launch Date to 6 Months Post-Launch Resources

Brand 11

  • Launch Date to 6 Months Post-Launch Resources

Brand 12

  • Phase 3a to Market Approval Resources
  • Market Approval to Launch Date Resources
  • Launch Date to 6 Months Post-Launch Resources

Brand 13

  • Market Approval to Launch Date Resources
  • Launch Date to 6 Months Post-Launch Resources

Brand 14

  • Phase 3a to Market Approval Resources
  • Market Approval to Launch Date Resources
  • Launch Date to 6 Months Post-Launch Resources

Brand 15

  • Phase 3a to Market Approval Resources
  • Market Approval to Launch Date Resources
  • Launch Date to 6 Months Post-Launch Resources

Average Spending by Category

  • Phase 3a to Market Approval
  • Market Approval to Launch Date
  • Launch Date to 6 Months Post-Launch

CHARTS AND GRAPHICS

Executive Summary

Pharmaceutical Product Commercialization: Key Recommendations for Success

  • Figure E.1: Phase 3a to Market Approval Average Spending Allocation (US Launches)
  • Figure E.2: Average Spending Mix: Phase 3a to Market Approval (US Launches)
  • Figure E.3: Average Spending Mix: Market Approval to Launch (US Launches)
  • Figure E.4: Average Spending Mix: Launch Date to 6 Months Post-Launch (US Launches)
  • Figure E.5: Average Digital Marketing Spending (US Launches)

Brand 1

  • Figure 1.1: Brand 1 Launch Details and Timeline
  • Figure 1.2: Brand 1 Market Environment and Development
  • Figure 1.3: Brand 1 (Expected) Peak Sales
  • Figure 1.4: Brand 1 Total Commercialization Spending by Time Period

Phase 3a to Market Approval Resources

  • Figure 1.5: Brand 1 Phase 3a to Market Approval Spending
  • Figure 1.6: Brand 1 Phase 3a to Market Approval Spending Percentage Breakdown
  • Figure 1.7: Brand 1 Market Approval to Launch Date Spending

Market Approval to Launch Date Resources

  • Figure 1.8: Brand 1 Market Approval to Launch Date Spending Percentage Breakdown
  • Figure 1.9: Brand 1 Launch Date to 6 Months Post-Launch Spending

Launch Date to 6 Months Post-Launch Resources

  • Figure 1.10: Brand 1 Launch Date to 6 Months Post-Launch Spending Percentage Breakdown

Individual Spending Categories by Time Frame

  • Figure 1.11: Brand 1 Medical Education (Including but not limited to CME) Spending
  • Figure 1.12: Brand 1 Medical Information Spending
  • Figure 1.13: Brand 1 Thought Leader Activities/MSL Programs Spending
  • Figure 1.14: Brand 1 Medical Publications Spending
  • Figure 1.15: Brand Market Research Spending
  • Figure 1.16: Brand 1 Competitive Intelligence Spending
  • Figure 1.17: Brand 1 Health Economics and Outcomes Research Spending
  • Figure 1.18: Brand 1 Pricing and Reimbursement Spending
  • Figure 1.19: Brand 1 Detail Aids and Promotional Materials Spending
  • Figure 1.20: Brand 1 Promotional Speaker Programs Spending
  • Figure 1.21: Brand 1 Congresses, Symposia and Conference Promotions Spending
  • Figure 1.22: Brand 1 Digital Marketing Spending
  • Figure 1.23: Brand 1 Physician Support Programs Spending
  • Figure 1.24: Brand 1 Print Journal Ads Spending
  • Figure 1.25: Brand 1 Patient Communication and Education Spending

Brand 2

  • Figure 2.1: Brand 2 Launch Details and Timeline
  • Figure 2.2: Brand 2 Market Environment and Development
  • Figure 2.3: Brand 2 (Expected) Peak Sales
  • Figure 2.4: Brand 2 Total Commercialization Spending by Time Period
  • Figure 2.5: Brand 2 Phase 3a to Market Approval Spending

Phase 3a to Market Approval Resources

  • Figure 2.6: Brand 2 Phase 3a to Market Approval Spending Percentage Breakdown
  • Figure 2.7: Brand 2 Market Approval to Launch Date Spending

Market Approval to Launch Date Resources

  • Figure 2.8: Brand 2 Market Approval to Launch Date Spending Percentage Breakdown
  • Figure 2.9: Brand 2 Launch Date to 6 Months Post-Launch Spending

Launch Date to 6 Months Post-Launch Resources

  • Figure 2.10: Brand 2 Launch Date to 6 Months Post-Launch Spending Percentage Breakdown
  • Figure 2.11: Brand 2 Medical Education (Including but Not Limited to CME) Spending
  • Figure 2.12: Brand 2 Thought Leader Activities/MSL Programs Spending
  • Figure 2.13: Brand 2 Medical Publications Spending
  • Figure 2.14: Brand 2 Market Research Spending
  • Figure 2.15: Brand 2 Competitive Intelligence Spending
  • Figure 2.16: Brand 2 Health Economics and Outcomes Research Spending
  • Figure 2.17: Brand 2 Detail Aids and Promotional Materials Spending
  • Figure 2.18: Brand 2 Promotional Speaker Programs Spending
  • Figure 2.19: Brand 2 Congresses, Symposia and Conference Promotions Spending
  • Figure 2.20: Brand 2 Digital Marketing Spending
  • Figure 2.21: Brand 2 Print Journal Ads Spending
  • Figure 2.22: Brand 2 Direct-to-Consumer Advertising Spending
  • Figure 2.23: Brand 2 Patient Communication and Education Spending

Brand 3

  • Figure 3.1: Brand 3 Launch Details and Timeline
  • Figure 3.2: Brand 3 Market Environment and Development
  • Figure 3.3: Brand 3 (Expected) Peak Sales
  • Figure 3.4: Brand 3 Total Commercialization Spending by Time Period
  • Figure 3.5: Brand 3 Phase 3a to Market Approval Spending

Phase 3a to Market Approval Resources

  • Figure 3.6: Brand 3 Phase 3a to Market Approval Spending Percentage Breakdown
  • Figure 3.7: Brand 3 Market Approval to Launch Date Spending

Market Approval to Launch Date Resources

  • Figure 3.8: Brand 3 Market Approval to Launch Date Spending
  • Figure 3.9: Brand 3 Market Approval to Launch Date Spending Percentage Breakdown
  • Figure 3.10: Brand 3 Launch Date to 6 Months Post-Launch Spending

Launch Date to 6 Months Post-Launch Resources

  • Figure 3.11: Brand 3 Launch Date to 6 Months Post-Launch Spending Percentage Breakdown
  • Figure 3.12: Brand 3 Medical Education (Including but not Limited to CME) Spending
  • Figure 3.13: Brand 3 Thought Leader Activities/MSL Programs Spending
  • Figure 3.14: Brand 3 Medical Publications Spending
  • Figure 3.15: Brand 3 Market Research Spending
  • Figure 3.16: Brand 3 Competitive Intelligence Spending
  • Figure 3.17: Brand 3 Health Economics and Outcomes Research Spending
  • Figure 3.18: Brand 3 Pricing and Reimbursement Spending
  • Figure 3.19: Brand 3 Detail Aids and Promotional Materials Spending
  • Figure 3.20: Brand 3 Print Journal Ads Spending
  • Figure 3.21: Brand 3 Patient Communication and Education Spending

Brand 4

  • Figure 4.1: Brand 4 Launch Details and Timeline
  • Figure 4.2: Brand 4 Market Environment and Development
  • Figure 4.3: Brand 4 (Expected) Peak Sales
  • Figure 4.4: Brand 4 Total Commercialization Spending by Time Period
  • Figure 4.5: Brand 4 Phase 3a to Market Approval Spending

Phase 3a to Market Approval Resources

  • Figure 4.6: Brand 4 Phase 3a to Market Approval Spending Percentage Breakdown

Market Approval to Launch Date Resources

  • Figure 4.7: Brand 4 Launch Date to 6 Months Post-Launch Spending

Launch Date to 6 Months Post-Launch Resources

  • Figure 4.8: Brand 4 Launch Date to 6 Months Post-Launch Spending Percentage Breakdown
  • Figure 4.9: Brand 4 Medical Education (including but not limited to CME) Spending
  • Figure 4.10: Brand 4 Medical Information Spending
  • Figure 4.11: Brand 4 Thought Leader Activities/MSL Programs Spending
  • Figure 4.12: Brand 4 Medical Publications Spending
  • Figure 4.13: Brand 4 Market Research Spending
  • Figure 4.14: Brand 4 Competitive Intelligence Spending
  • Figure 4.15: Brand 4 Health Economics and Outcomes Research Spending
  • Figure 4.16: Brand 4 Detail Aids and Promotional Materials Spending
  • Figure 4.17: Brand 4 Promotional Speaker Programs Spending
  • Figure 4.18: Brand 4 Congresses, Symposia and Conference Promotions Spending
  • Figure 4.19: Brand 4 Digital Marketing Spending
  • Figure 4.21: Brand 4 Print Journal Ads Spending
  • Figure 4.20: Brand 4 Physician Support Programs Spending
  • Figure 4.22: Brand 4 Patient Communication and Education Spending

Brand 5

  • Figure 5.1: Brand 5 Launch Details and Timeline
  • Figure 5.2: Brand 5 Market Environment and Development
  • Figure 5.3: Brand 5 (Expected) Peak Sales
  • Figure 5.4: Brand 5 Total Commercialization Spending by Time Period
  • Figure 5.5: Brand 5 Phase 3a to Market Approval Spending

Phase 3a to Market Approval Resources

  • Figure 5.6: Brand 5 Phase 3a to Market Approval Spending Percentage Breakdown
  • Figure 5.7: Brand 5 Medical Education (including but not limited to CME) Spending
  • Figure 5.8: Brand 5 Medical Information Spending
  • Figure 5.9: Brand 5 Thought Leader Activities/MSL Programs Spending
  • Figure 5.10: Brand 5 Medical Publications Spending
  • Figure 5.11: Brand 5 Market Research Spending
  • Figure 5.12: Brand 5 Competitive Intelligence Spending
  • Figure 5.14: Brand 5 Pricing and Reimbursement Spending
  • Figure 5.13: Brand 5 Health Economics and Outcomes Research Spending
  • Figure 5.15: Brand 5 Detail Aids and Promotional Materials Spending
  • Figure 5.16: Brand 5 Promotional Speaker Programs Spending
  • Figure 5.17: Brand 5 Congresses, Symposia and Conference Promotions Spending
  • Figure 5.18: Brand 5 Digital Marketing Spending
  • Figure 5.19: Brand 5 Physician Support Programs Spending
  • Figure 5.20: Brand 5 Patient Communication and Education Spending

Brand 6

  • Figure 6.1: Brand 6 Launch Details and Timeline
  • Figure 6.2: Brand 6 Market Environment and Development
  • Figure 6.3: Brand 6 (Expected) Peak Sales
  • Figure 6.4: Brand 6 Phase 3a to Market Approval Spending

Phase 3a to Market Approval Resources

Brand 7

  • Figure 7.1: Brand 7 Launch Details and Timeline
  • Figure 7.2: Brand 7 Market Environment and Development
  • Figure 7.3: Brand 7 (Expected) Peak Sales
  • Figure 7.4: Brand 7 Total Commercialization Spending by Time Period
  • Figure 7.5: Brand 7 Phase 3a to Market Approval Spending

Phase 3a to Market Approval Resources

  • Figure 7.6: Brand 7 Phase 3a to Market Approval Spending Percentage Breakdown
  • Figure 7.7: Brand 7 Market Approval to Launch Date Spending

Launch Date to 6 Months Post-Launch Resources

  • Figure 7.8: Brand 7 Launch Date to 6 Months Post-Launch Spending
  • Figure 7.9: Brand 7 Launch Date to 6 Months Post-Launch Spending Percentage Breakdown
  • Figure 7.10: Brand 7 Medical Education (including but Not Limited to CME) Spending
  • Figure 7.11: Brand 7 Thought Leader Activities/MSL Programs Spending
  • Figure 7.12: Brand 7 Medical Publications Spending
  • Figure 7.13: Brand 7 Pricing and Reimbursement Spending
  • Figure 7.14: Brand 7 Detail Aids and Promotional Materials Spending
  • Figure 7.15: Brand 7 Promotional Speaker Programs Spending
  • Figure 7.16: Brand 7 Congresses, Symposia and Conference Promotions Spending
  • Figure 7.17: Brand 7 Print Journal Ads Spending
  • Figure 7.18: Brand 7 Direct-to-Consumer Advertising Spending
  • Figure 7.19: Brand 7 Patient Communication and Education Spending

Brand 8

  • Figure 8.1: Brand 8 Launch Details and Timeline
  • Figure 8.2: Brand 8 Market Environment and Development
  • Figure 8.3: Brand 8 (Expected) Peak Sales
  • Figure 8.4: Brand 8 Total Commercialization Spending by Time Period
  • Figure 8.5: Brand 8 Market Approval to Launch Date Spending

Market Approval to Launch Date Resources

  • Figure 8.6: Brand 8 Market Approval to Launch Date Spending Percentage Breakdown
  • Figure 8.7: Brand 8 Launch Date to 6 Months Post-Launch Spending

Launch Date to 6 Months Post-Launch Resources

  • Figure 8.8: Brand 8 Launch Date to 6 Months Post-Launch Spending Percentage Breakdown
  • Figure 8.9: Brand 8 Medical Education (including but not limited to CME) Spending
  • Figure 8.10: Brand 8 Medical Information Spending
  • Figure 8.11: Brand 8 Thought Leader Activities/MSL Programs Spending
  • Figure 8.12: Brand 8 Medical Publications Spending
  • Figure 8.13: Brand 8 Market Research Spending
  • Figure 8.14: Brand 8 Competitive Intelligence Spending
  • Figure 8.15: Brand 8 Health Economics and Outcomes Research Spending
  • Figure 8.16: Brand 8 Pricing and Reimbursement Spending
  • Figure 8.17: Brand 8 Detail Aids and Promotional Materials Spending
  • Figure 8.18: Brand 8 Promotional Speaker Programs Spending
  • Figure 8.19: Brand 8 Congresses, Symposia and Conference Promotions Spending
  • Figure 8.20: Brand 8 Digital Marketing Spending
  • Figure 8.21: Brand 8 Print Journal Ads Spending
  • Figure 8.22: Brand 8 Patient Communication and Education Spending

Brand 9

  • Figure 9.1: Brand 9 Launch Details and Timeline
  • Figure 9.2: Brand 9 Market Environment and Development
  • Figure 9.3: Brand 9 (Expected) Peak Sales
  • Figure 9.4: Brand 9 Total Commercialization Spending by Time Period
  • Figure 9.5: Brand 9 Market Approval to Launch Date Spending

Market Approval to Launch Date Resources

  • Figure 9.6: Brand 9 Market Approval to Launch Date Spending Percentage Breakdown

Launch Date to 6 Months Post-Launch Resources

  • Figure 9.7: Brand 9 Launch Date to 6 Months Post-Launch Spending
  • Figure 9.8: Brand 9 Launch Date to 6 Months Post-Launch Spending Percentage Breakdown
  • Figure 9.9: Brand 9 Medical Education (including but not limited to CME) Spending
  • Figure 9.10: Brand 9 Medical Information Spending
  • Figure 9.11: Brand 9 Thought Leader Activities/MSL Programs Spending
  • Figure 9.12: Brand 9 Medical Publications Spending
  • Figure 9.13: Brand Market Research Spending
  • Figure 9.14: Brand 9 Competitive Intelligence Spending
  • Figure 9.15: Brand 9 Health Economics and Outcomes Research Spending
  • Figure 9.16: Brand 9 Pricing and Reimbursement Spending
  • Figure 9.17: Brand 9 Detail Aids and Promotional Materials Spending
  • Figure 9.18: Brand 9 Promotional Speaker Programs Spending
  • Figure 9.19: Brand 9 Congresses, Symposia and Conference Promotions Spending
  • Figure 9.20: Brand 9 Digital Marketing Spending
  • Figure 9.21: Brand 9 Physician Support Programs Spending
  • Figure 9.22: Brand 9 Print Journal Ads Spending
  • Figure 9.23: Brand 9 Patient Communication and Education Spending

Brand 10

  • Figure 10.1: Brand 10 Launch Details and Timeline
  • Figure 10.2: Brand 10 Market Environment and Development
  • Figure 10.3: Brand 10 (Expected) Peak Sales
  • Figure 10.4: Brand 10 Total Commercialization Spending by Time Period

Phase 3a to Market Approval Resources

  • Figure 10.5: Brand 10 Phase 3a to Market Approval Spending
  • Figure 10.6: Brand 10 Phase 3a to Market Approval Spending Percentage Breakdown
  • Figure 10.7: Brand 10 Market Approval to Launch Date Spending

Market Approval to Launch Date Resources

  • Figure 10.8: Brand 10 Market Approval to Launch Date Spending Percentage Breakdown
  • Figure 10.9: Brand 10 Launch Date to 6 Months Post-Launch Spending

Launch Date to 6 Months Post-Launch Resources

  • Figure 10.10: Brand 10 Launch Date to 6 Months Post-LaunchSpending Percentage Breakdown
  • Figure 10.11: Brand 10 Medical Education (Including but Not Limited to CME) Spending
  • Figure 10.12: Brand 10 Medical Information Spending
  • Figure 10.13: Brand 10 Thought Leader Activities/MSL Programs Spending
  • Figure 10.14: Brand 10 Medical Publications Spending
  • Figure 10.15: Brand Market Research Spending
  • Figure 10.16: Brand 10 Competitive Intelligence Spending
  • Figure 10.17: Brand 10 Health Economics and Outcomes Research Spending
  • Figure 10.18: Brand 10 Pricing and Reimbursement Spending
  • Figure 10.19: Brand 10 Detail Aids and Promotional Materials Spending
  • Figure 10.20: Brand 10 Promotional Speaker Programs Spending
  • Figure 10.21: Brand 10 Congresses, Symposia and Conference Promotions Spending
  • Figure 10.22: Brand 10 Digital Marketing Spending
  • Figure 10.23: Brand 10 Physician Support Programs Spending
  • Figure 10.25: Brand 10 Patient Communication and Education Spending
  • Figure 10.24: Brand 10 Print Journal Ads Spending
  • Figure 11.1: Brand 11 Launch Details and Timeline

Brand 11

  • Figure 11.2: Brand 11 Market Environment and Development
  • Figure 11.3: Brand 11 (Expected) Peak Sales
  • Figure 11.4: Brand 11 Launch Date to 6 Months Post-Launch Spending

Launch Date to 6 Months Post-Launch Resources

  • Figure 11.5: Brand 11 Medical Education (Including but Not Limited to CME) Spending
  • Figure 11.6: Brand 11 Market Research Spending
  • Figure 11.7: Brand 11 Health Economics and Outcomes Research Spending
  • Figure 11.8: Brand 11 Detail Aids and Promotional Materials Spending
  • Figure 11.9: Brand 11 Congresses, Symposia and Conference Promotions Spending

Brand 12

  • Figure 12.1: Brand 12 Launch Details and Timeline
  • Figure 12.2: Brand 12 Market Environment and Development
  • Figure 12.3: Brand 12 (Expected) Peak Sales
  • Figure 12.4: Brand 12 Total Commercialization Spending by Time Period
  • Figure 12.5: Brand 12 Phase 3a to Market Approval Spending

Phase 3a to Market Approval Resources

  • Figure 12.6: Brand 12 Phase 3a to Market Approval Spending Percentage Breakdown

Market Approval to Launch Date Resources

  • Figure 12.7: Brand 12 Market Approval to Launch Date Spending
  • Figure 12.8: Brand 12 Market Approval to Launch Date Spending Percentage Breakdown

Launch Date to 6 Months Post-Launch Resources

  • Figure 12.9: Brand 12 Launch Date to 6 Months Post-Launch Spending
  • Figure 12.10: Brand 12 Launch Date to 6 Months Post-Launch Spending Percentage Breakdown
  • Figure 12.11: Brand 12 Medical Education (Including but Not Limited to CME) Spending
  • Figure 12.12: Brand 12 Medical Information Spending
  • Figure 12.13: Brand 12 Thought Leader Activities/MSL Programs Spending
  • Figure 12.14: Brand 12 Medical Publications Spending
  • Figure 12.15: Brand Market Research Spending
  • Figure 12.16: Brand 12 Competitive Intelligence Spending
  • Figure 12.17: Brand 12 Pricing and Reimbursement Spending
  • Figure 12.18: Brand 12 Detail Aids and Promotional Materials Spending
  • Figure 12.19: Brand 12 Promotional Speaker Programs Spending
  • Figure 12.20: Brand 12 Congresses, Symposia and Conference Promotions Spending
  • Figure 12.21: Brand 12 Digital Marketing Spending
  • Figure 12.22: Brand 12 Physician Support Programs Spending
  • Figure 12.23: Brand 12 Print Journal Ads Spending
  • Figure 12.24: Brand 12 Patient Communication and Education Spending

Brand 13

  • Figure 13.1: Brand 13 Launch Details and Timeline
  • Figure 13.2: Brand 13 Market Environment and Development
  • Figure 13.3: Brand 13 (Expected) Peak Sales, US and EU
  • Figure 13.4: Brand 13 (Expected) Peak Sales, Canada
  • Figure 13.5: Brand 13 Total Commercialization Spending by Time Period

Market Approval to Launch Date Resources

  • Figure 13.6: Brand 13 Market Approval to Launch Date Spending
  • Figure 13.7: Brand 13 Market Approval to Launch Date Spending Percentage Breakdown

Launch Date to 6 Months Post-Launch Resources

  • Figure 13.8: Brand 13 Launch Date to 6 Months Post-Launch Spending
  • Figure 13.9: Brand 13 Launch Date to 6 Months Post-Launch Spending Percentage Breakdown
  • Figure 13.10: Brand 13 Medical Education (including but not Liimited to CME) Spending
  • Figure 13.11: Brand 13 Medical Information Spending
  • Figure 13.12: Brand 13 Thought Leader Activities/MSL Programs Spending
  • Figure 13.13: Brand 13 Market Research Spending
  • Figure 13.14: Brand 13 Competitive Intelligence Spending
  • Figure 13.15: Brand 13 Health Economics and Outcomes Research Spending
  • Figure 13.16: Brand 13 Pricing and Reimbursement Spending
  • Figure 13.17: Brand 13 Detail Aids and Promotional Materials Spending
  • Figure 13.19: Brand 13 Congresses, Symposia and Conference Promotions Spending
  • Figure 13.18: Brand 13 Promotional Speaker Programs Spending
  • Figure 13.20: Brand 13 Print Journal Ads Spending
  • Figure 13.21: Brand 13 Patient Communication and Education Spending

Brand 14

  • Figure 14.1: Brand 14 Launch Details and Timeline
  • Figure 14.2: Brand 14 Market Environment and Development
  • Figure 14.3: Brand 14 (Expected) Peak Sales
  • Figure 14.4: Brand 14 Total Commercialization Spending by Time Period
  • Figure 14.5: Brand 14 Phase 3a to Market Approval Spending

Phase 3a to Market Approval Resources

  • Figure 14.6: Brand 14 Phase 3a to Market Approval Spending Percentage Breakdown

Market Approval to Launch Date Resources

Launch Date to 6 Months Post-Launch Resources

  • Figure 14.7: Brand 14 Launch Date to 6 Months Post-Launch Spending
  • Figure 14.8: Brand 14 Launch Date to 6 Months Post-Launch Spending Percentage Breakdown
  • Figure 14.9: Brand 14 Medical Education (Including but Not Limited to CME) Spending
  • Figure 14.10: Brand 14 Medical Information Spending
  • Figure 14.11: Brand 14 Thought Leader Activities/MSL Programs Spending
  • Figure 14.12: Brand 14 Medical Publications Spending
  • Figure 14.13: Brand Market Research Spending
  • Figure 14.14: Brand 14 Competitive Intelligence Spending
  • Figure 14.15: Brand 14 Health Economics and Outcomes Research Spending
  • Figure 14.16: Brand 14 Pricing and Reimbursement Spending
  • Figure 14.17: Brand 14 Detail Aids and Promotional Materials Spending
  • Figure 14.18: Brand 14 Promotional Speaker Programs Spending
  • Figure 14.19: Brand 14 Congresses, Symposia and Conference Promotions Spending
  • Figure 14.20: Brand 14 Digital Marketing Spending
  • Figure 14.21: Brand 14 Physician Support Programs Spending
  • Figure 14.22: Brand 14 Print Journal Ads Spending
  • Figure 14.23: Brand 14 Patient Communication and Education Spending

Brand 15

  • Figure 15.1: Brand 15 Launch Details and Timeline
  • Figure 15.2: Brand 15 Market Environment and Development
  • Figure 15.3: Brand 15 (Expected) Peak Sales
  • Figure 15.4: Brand 15 Total Commercialization Spending by Time Period
  • Figure 15.5: Brand 15 Market Approval to Launch Date Spending

Market Approval to Launch Date Resources

  • Figure 15.6: Brand 15 Market Approval to Launch Date Spending Percentage Breakdown
  • Figure 15.7: Brand 15 Launch Date to 6 Months Post-Launch Spending

Launch Date to 6 Months Post-Launch Resources

  • Figure 15.9: Brand 15 Medical Education (including but Not Limited to CME) Spending
  • Figure 15.8: Brand 15 Launch Date to 6 Months Post-Launch Spending Percentage Breakdown
  • Figure 15.11: Brand 15 Thought Leader Activities/MSL Programs Spending
  • Figure 15.10: Brand 15 Medical Information Spending
  • Figure 15.12: Brand 15 Medical Publications Spending
  • Figure 15.13: Brand 15 Market Research Spending
  • Figure 15.15: Brand 15 Health Economics and Outcomes Research Spending
  • Figure 15.14: Brand 15 Competitive Intelligence Spending
  • Figure 15.16: Brand 15 Detail Aids and Promotional Materials Spending
  • Figure 15.17: Brand 15 Promotional Speaker Programs Spending
  • Figure 15.18: Brand 15 Congresses, Symposia and Conference Promotions Spending
  • Figure 15.19: Brand 15 Physician Support Programs Spending
  • Figure 15.21: Brand 15 Patient Communication and Education Spending
  • Figure 15.20: Brand 15 Print Journal Ads Spending

Average Spending by Category

  • Figure 16.1: Phase 3a to Market Approval Average Spending Mix (US Launches)
  • Figure 16.2: Phase 3a to Market Approval Average Spending Mix (US Launches)

Phase 3a to Market Approval

  • Figure 16.3: Phase 3a to Market Approval Medical Education Spending (US Launches)
  • Figure 16.4: Phase 3a to Market Approval Medical Information Spending (US Launches)
  • Figure 16.5: Phase 3a to Market Approval Thought Leader Activities/MSL Programs Spending (US Launches)
  • Figure 16.6: Phase 3a to Market Approval Medical Publications Spending (US Launches)
  • Figure 16.7: Phase 3a to Market Approval Market Research Spending (US Launches)
  • Figure 16.8: Phase 3a to Market Approval Competitive Intelligence Spending (US Launches)
  • Figure 16.9: Phase 3a to Market Approval Health Economics and Outcomes Research Spending (US Launches)
  • Figure 16.10: Phase 3a to Market Approval Pricing and Reimbursement Spending (US Launches)
  • Figure 16.11: Phase 3a to Market Approval Detail Aids and Promotional Materials Spending (US Launches)
  • Figure 16.12: Phase 3a to Market Approval Print Journal Ads Spending (US Launches)
  • Figure 16.13: Phase 3a to Market Approval Promotional Speaker Programs Spending (US Launches)
  • Figure 16.14: Phase 3a to Market Approval Congresses, Symposia and Conference Promotions Spending (US Launches)
  • Figure 16.15: Phase 3a to Market Approval Digital Marketing Spending (US Launches)
  • Figure 16.16: Phase 3a to Market Approval Physician Support Programs Spending (US Launches)
  • Figure 16.17: Phase 3a to Market Approval Patient Communication and Education Spending (US Launches)

Market Approval to Launch Date

  • Figure 16.18: Market Approval to Launch Date Average Spending Mix (US Launches)
  • Figure 16.19: Market Approval to Launch Date Average Spending Mix (US Launches)
  • Figure 16.20: Market Approval to Launch Date Medical Education Spending (US Launches)
  • Figure 16.21: Market Approval to Launch Date Medical Information Spending (US Launches)
  • Figure 16.22: Market Approval to Launch Date Thought Leader Activities/MSL Programs Spending (US Launches)
  • Figure 16.23: Market Approval to Launch Date Medical Publications Spending (US Launches)
  • Figure 16.24: Market Approval to Launch Date Market Research Spending (US Launches)
  • Figure 16.25: Market Approval to Launch Date Competitive Intelligence Spending (US Launches)
  • Figure 16.26: Market Approval to Launch Date Health Economics and Outcomes Research Spending (US Launches)
  • Figure 16.27: Market Approval to Launch Date Pricing and Reimbursement Spending (US Launches)
  • Figure 16.28: Market Approval to Launch Date Detail Aids and Promotional Materials Spending (US Launches)
  • Figure 16.29: Market Approval to Launch Date Print Journal Ads Spending (US Launches)
  • Figure 16.30: Market Approval to Launch Date Promotional Speaker Programs Spending (US Launches)
  • Figure 16.31: Market Approval to Launch Date Congresses, Symposia and Conference Promotions Spending (US Launches)
  • Figure 16.32: Market Approval to Launch Date Digital Marketing Spending (US Launches)
  • Figure 16.33: Market Approval to Launch Date Physician Support Programs Spending (US Launches)
  • Figure 16.34: Market Approval to Launch Date Patient Communication and Education Spending (US Launches)
  • Figure 16.35: Launch Date to 6 Months Post-Launch Average Spending Mix (US Launches)
  • Figure 16.36: Launch Date to 6 Months Post-Launch Average Spending Mix (US Launches)

Launch Date to 6 Months Post-Launch

  • Figure 16.37: Launch Date to 6 Months Post-Launch Medical Education Spending (US Launches)
  • Figure 16.38: Launch Date to 6 Months Post-Launch Medical Information Spending (US Launches)
  • Figure 16.39: Launch Date to 6 Months Post-Launch Thought Leader Activities/MSL Programs Spending (US Launches)
  • Figure 16.40: Launch Date to 6 Months Post-Launch Medical Publications Spending (US Launches)
  • Figure 16.41: Launch Date to 6 Months Post-Launch Market Research Spending (US Launches)
  • Figure 16.42: Launch Date to 6 Months Post-Launch Competitive Intelligence Spending (US Launches)
  • Figure 16.43: Launch Date to 6 Months Post-Launch Health Economics and Outcomes Research Spending (US Launches)
  • Figure 16.44: Launch Date to 6 Months Post-Launch Pricing and Reimbursement Spending (US Launches)
  • Figure 16.45: Launch Date to 6 Months Post-Launch Detail Aids and Promotional Materials Spending (US Launches)
  • Figure 16.46: Launch Date to 6 Months Post-Launch Print Journal Ads Spending (US Launches)
  • Figure 16.47: Launch Date to 6 Months Post-Launch Promotional Speaker Programs Spending (US Launches)
  • Figure 16.48: Launch Date to 6 Months Post-Launch Congresses, Symposia and Conference Promotions Spending (US Launches)
  • Figure 16.49: Launch Date to 6 Months Post-Launch Digital Marketing Spending (US Launches)
  • Figure 16.50: Launch Date to 6 Months Post-Launch Physician Support Programs Spending (US Launches)
  • Figure 16.51: Launch Date to 6 Months Post-Launch Patient Communication and Education Spending (US Launches)
Back to Top